These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9951331)

  • 41. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis.
    Stoehr GA; Luecken J; Zielen S; Eber SW; Borrow R; Rose MA
    Br J Surg; 2008 Apr; 95(4):466-71. PubMed ID: 18161897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
    J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Meningococcal vaccination: which one? When? Why?].
    Rosenheim M
    Rev Prat; 2004 Mar; 54(5):512-8. PubMed ID: 15176510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the epidemic of acute meningococcosis in Belgium. Study of 60 patients and their families (1972-1973)].
    Linz R; Lecocq E; Custermans L; Lejour M; Mommens M
    Arch Belg Med Soc; 1973; 31(9):569-87. PubMed ID: 4791021
    [No Abstract]   [Full Text] [Related]  

  • 47. [Vaccinations. Immunologic and microbiologic principles, indications, contraindications, accidents, efficacy (schedule and compulsory aspects of vaccination excluded)].
    Baron S; Lévy-Bruhl D; Drucker J
    Rev Prat; 1998 Mar; 48(5):539-44. PubMed ID: 9781119
    [No Abstract]   [Full Text] [Related]  

  • 48. [Epidemiology of meningococcal infection in the province of Seville (1962-1963 to 1981-1982)].
    Blasco Huelva PM; García Serna D
    Rev Sanid Hig Publica (Madr); 1985; 59(3-4):395-416. PubMed ID: 4081604
    [No Abstract]   [Full Text] [Related]  

  • 49. [Meningococcal infections in Quebec, 1991-1992].
    Union Med Can; 1992; 121(6):372-3. PubMed ID: 1481298
    [No Abstract]   [Full Text] [Related]  

  • 50. [Public statement of the Chilean Infectious Diseases Society about changes to the national schedule of vaccination against meningococcal disease].
    Muñoz A; Contreras L; Potin M; Cerda J; Domínguez I; Fica A; Véliz L
    Rev Chilena Infectol; 2014 Feb; 31(1):53. PubMed ID: 24740775
    [No Abstract]   [Full Text] [Related]  

  • 51. [Meningococcal infections in Arhus and surrounding communities in 1974].
    Romer FK
    Ugeskr Laeger; 1975 Dec; 137(49):2883-7. PubMed ID: 1198721
    [No Abstract]   [Full Text] [Related]  

  • 52. [Approaches to an epidemiological survey of meningococcal infection].
    Ivanova TG; Dudareva VV; Kaganer EB; Iafaev RKh
    Tr Inst Im Pastera; 1982; 57():145-8. PubMed ID: 6221442
    [No Abstract]   [Full Text] [Related]  

  • 53. [Vaccination schedules on Spanish territory. Necessity of unification and execution].
    Barbancho Cisneros FJ; Tirado Altamirano F; Redondo Antequera J
    Rev Enferm; 1997 Dec; 20(232):49-55. PubMed ID: 9485860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meningococcal infections: sixteen years' experience.
    Saxe TG; Finch RG
    W V Med J; 1978 May; 74(5):99-102. PubMed ID: 274017
    [No Abstract]   [Full Text] [Related]  

  • 55. [Updating vaccination schedules in public health].
    Lloréns J; Figueras G
    An Esp Pediatr; 1988 Sep; 29 Suppl 33():33-8. PubMed ID: 3250296
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cellular immunity indices in generalized forms of meningococcal infection].
    Arbekova VP
    Vopr Okhr Materin Det; 1980 Sep; 25(9):43-5. PubMed ID: 6999727
    [No Abstract]   [Full Text] [Related]  

  • 57. Active immunization of infants and children.
    Srouji ES
    J Med Liban; 1974; 27(3):369-74. PubMed ID: 4609351
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vaccination policy for children in France].
    Monnet P
    Rev Prat; 1984 Jun; 34(31):1659-64. PubMed ID: 6740170
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunological factors in the evolution of the epidemic process in meningococcal infection].
    Demina AA; Martynov IuV; Deviatkina NP; Gracheva AM; Larina LI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):29-34. PubMed ID: 2529720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Humoral immunity in various forms of meningococcal infection].
    Arbekova VP
    Vopr Okhr Materin Det; 1975 Sep; 20(9):46-8. PubMed ID: 1224548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.